Additionally, BRCA and KIRP patients with high-expressed CBX2 showed worse overall survival while BRCA, KIRP, KIRC, LUAD and PAAD patients with high-expressed CEP55 showed worse survival (Figure 7A, 7C). The gene discussed is CBX2; the disease is pancreatic adenocarcinoma.